Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01912989 · ClinicalTrials.gov registry record · NA

Motivational Interviewing in NOURISH for Parents of Overweight Children

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
64
Enrollment target

NCT01912989: Completed NA study, sponsored by Virginia Commonwealth University.

NCT01912989 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 64 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01912989, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
64 participants
Enrollment target

Study Summary

The purpose of this study is to investigate if a brief, motivational interviewing intervention (NOURISH+MI) can improve retention and treatment adherence for parents enrolled in an intervention for their child's overweight (NOURISH+). The investigators hypothesize that children whose parents participate in NOURISH+MI will demonstrate lower attrition and greater adherence with NOURISH+, ultimately leading to greater treatment effects, compared with children whose parents are randomized to NOURISH+ or a control group.

Interventions

  • BEHAVIORAL Lifestyle counseling

Trial Details

FieldValue
Enrollment Target 64 participants
Start Date 2013-01
Est. Completion 2015-08
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT01912989 record still lists

NCT01912989 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Lifestyle counseling is the first listed.

NCT01912989 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01912989 about?

NCT01912989 is a clinical study titled "Motivational Interviewing in NOURISH for Parents of Overweight Children". The purpose of this study is to investigate if a brief, motivational interviewing intervention (NOURISH+MI) can improve retention and treatment adherence for parents enrolled in an intervention for their child's overweight (NOURISH+). The investigators hypothesize that children whose parents partici...

What is the current status of trial NCT01912989?

This trial is currently completed. It is a NA study. The enrollment target is 64 participants. The study started on 2013-01. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01912989?

The interventions under investigation include: Lifestyle counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT01912989?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01912989's enrollment target sits among peer trials

64 1147th of 2000 higher than 844 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01853631 · 64 participants · Phase 1

    Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

  • NCT03739502 · 64 participants · Phase 2

    A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant

  • NCT03739814 · 64 participants · Phase 2

    Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

  • NCT03866408 · 64 participants · Early Phase 1

    Insulin Regulation of Lipolysis and Lipolysis Proteins

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01912989, the US trial registry maintained by the National Library of Medicine. NCT01912989 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.